Megan (Der Yu) Wang

• Support data compilation for safety evaluation of the study • Review response assessments for phase III lymphoma study • Perform and delegate data review listings for phase Ib and phase III lymphoma studies • Review and support study related clinical science documentations (e.g. protocol amendment, investigator brochure, charter, protocol deviation) • Identify and resolve external and internal study-related issues and streamline the study • Develop experiences in strategic clinical development role • Attend international conferences (The American Society of Hematology conference) to meet with the key opinion leaders within the hematological field • Involve with healthy volunteer study to advance the strategic pharmacokinetic study planning • Participate in competitive intelligence for the Non-Hodgkin Lymphoma landscape • Present study protocol overview to the Global Medical Scientist Liaison team • Collaborate with cross-functional teams (e.g. medical monitors, clinical operation, data management, clinical pharmacology, statistical programming, etc.) in supporting phase 3 lymphoma studies

• Supporting the product’s future direction by providing scientific evidence • Networking with professionals in different functions of the pharmacy industry • Attended meetings that address the progression of products • Presented novel approved drugs to clinical science team

• Oversaw entire operation of the clinical study and served as a research coordinator to implement IRB-approved protocols, coordinated participants’ schedules, study locations, and addressed any issues or concerns that arose during the study period • Designed clinical study protocol and drafted IRB application for this randomized controled trial • Delegated tasks among the research team • Resolved problems (e.g. withdrawal from study, compliance) as they arose throughout the study period • Defended design and implementations of the study at a mock legal trial

• Measured vasculature response in UC Davis-type 2 diabetic rats • Optimized experimental procedures by changing the antibody used to better detect protein expression in vascular tissue • Managed proper laboratory inventory

• Designed poster presentation and presented results of the retrospective/prospective study at the 2018 CSHP meeting • Conducted patient data collection from different electronic health record systems (i.e. Cerner and Meditech) • Organized and analyzed data to test hypothesis

• Established communication with providers regarding regimen adjustments • Provided consultations for patients

• Operated in specialty pharmacy facilities: emergency/discharge, pediatric, compounding, oncology, and traveling medicine • Managed pharmacy inventory

• Trained high school students on proper laboratory techniques • Prepared necessary laboratory supplies for experiments

• Designed project related to ocean acidification • Collected field samples in collaboration with research scientists • Established water sample standards